PHES scores have limited impact on the risk of overt HE in patients with minimal HE.
Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Danneberg S, Sultanik P, Galle PR, Gioia S, Labenz J, Lok AS, Marquardt JU, Lauridsen MM, Bloom PP, Thabut D, Nardelli S, Montagnese S, Labenz C.
Gairing SJ, et al. Among authors: marquardt ju.
Hepatol Commun. 2024 May 3;8(5):e0438. doi: 10.1097/HC9.0000000000000438. eCollection 2024 May 1.
Hepatol Commun. 2024.
PMID: 38701395